Published in Clinical Oncology Week, May 7th, 2007
The new Pharmacor report Cancer Pain finds that the launch of Cephalon's Fentora and Cephalon/Zars' Titragesia will drive the market to treat breakthrough pain. In 2015, expensive novel formulations of fentanyl such as...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.